Proteomics Technologies Market Forecast Report | Global Analysis, Statistics And Revenue Research Report by 2028

Major players covered into report are Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, SGS SA, and PerkinElmer, Inc.

ISLE OF MAN, ISLE OF MAN, December 14, 2022 /EINPresswire.com/ -- Proteomics Technologies Market Size Analysis:

Proteomics is the most developed and rapidly evolving field of disease diagnosis. Proteomics is used to identify the proteins present in a particular disease and to gain an understanding of their structure, expression, and function. The proteomic study can also identify prognostic markers, which aid in the diagnosis of cancer, malaria, tuberculosis, and other infectious diseases. When it comes to the use of proteomics in the pharmaceutical industry, it plays a crucial role in the investigation of the drug's mechanism of action or its function. Proteomics is utilized in the development of pharmaceuticals, and numerous manufacturers have established proteomic divisions to increase their efficiency. The market for proteomics is anticipated to expand significantly during the forecast period.

Significant growth has occurred in personalized therapy, and the demand for this type of therapy is anticipated to increase in the coming years; consequently, the demand for proteomics will increase during the forecast period. Advanced protein interactions have played a crucial role in the development of personalized medicines. Proteomics has numerous applications, particularly in the field of nanotechnology. Nanostructured surfaces for protein separation and metal oxide nanoparticles are among its applications. Nanoproteomics is a recently emerging field that is anticipated to grow significantly in the coming years and provide significant market growth opportunities during the forecast period.

Numerous new technologies are anticipated to be incorporated into proteomics in the foreseeable future as a result of an increase in technical and financial research and development efforts. As the incidence of cancer and genetic disorders has increased significantly in recent years, it is anticipated that the demand for proteomics will increase substantially in the coming years. The characterization of the human proteome is a significant achievement in biomedicine, an extremely novel and dynamic field of study that focuses primarily on the proteome-level comprehension of gene expression.
The proteomics technologies market is expected to grow at a CAGR of around **% between 2017 and 2028.The growth is expected to be driven by increasing awareness about the importance of proteomics in drug discovery and development and expanding application areas such as biosensors, food testing, environmental monitoring, and clinical diagnostics.

Some of the key drivers that are fueling the growth of the global proteomics technologies market include increasing demand from pharmaceutical and biotechnology companies for advanced peptide identification tools; an increasing focus on biomarker discovery in cancer research; increasing applications in both academic and industrial settings; a growing number of large public-sector enterprises investing in proteomics R&D; and a rising need for customized solutions for specific applications.

Key Players: Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, SGS SA, and PerkinElmer, Inc.

Compare and choose your best-fitting market report here: https://douglasinsights.com/proteomics-technologies-market

COVID-19 Scenario:

The COVID-19 Scenario is a detailed analysis of the Proteomics Technologies market. The report covers the demand, trends, opportunities, challenges, risks factors analysis, competitive situation and key players.

Report Coverage:

The market has been segmented on the basis of technology, application, and region. The technology segment is projected to account for the largest share in the market, followed by application segment. The region-wise analysis reveals that North America is expected to lead the global proteomics technologies market in terms of revenue during the forecast period 2018-2028. Europe is also witnessing a significant growth owing to increasing investment in research and development activities. Asia Pacific is anticipated to witness a high growth rate due to increasing adoption of innovative proteomics technologies in various sectors such as healthcare, life sciences, and agricultural products. Latin America is expected to register a moderate growth rate owing to stringent regulations and limited investment opportunities.

Segmentations covered into report:

By Applications
• Applications in Cancer
• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Kidney Cancer
• Lung Cancer
• Lymphomas
• Ovarian Cancer
• Pan-Cancer
• Prostate Cancer
• Thyroid Cancer
• Other Cancers
• Infectious Diseases
• Diabetes
• Neurological Disorders
• Alzheimer's Disease
• Schizophrenia
• Immune Diseases
• HLA Typing
• Autoimmune Disease
• Cardiovascular Disease
• Preeclampsia

Customizes or specific data? Enquiry here - https://douglasinsights.com/static/contact-us

Key Questions Answered In This Report:

• Covid 19 impact analysis on global Proteomics Technologies Market industry.
• What are the current market trends and dynamics in the Proteomics Technologies Market and valuable opportunities for emerging players?
• What is driving Proteomics Technologies Market?
• What are the key challenges to market growth?
• Which segment accounts for the fastest CAGR during the forecast period?
• Which product type segment holds a larger market share and why?
• Are low and middle-income economies investing in the Proteomics Technologies Market?
• Key growth pockets on the basis of regions, types, applications, and end-users
• What is the market trend and dynamics in emerging markets such as Asia pacific, Latin America, and Middle East & Africa?

Unique data points of this report:

• Statistics on Proteomics Technologies Market and spending worldwide
• Recent trends across different regions in terms of adoption of Proteomics Technologies Market across industries
• Notable developments going on in the industry
• Attractive investment proposition for segments as well as geography
• Comparative scenario for all the segments for years 2018 (actual) and 2028 (forecast)

Table of Content:

Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing the Study
1.3 What's New in This Update?
1.4 Scope of Report
1.5 Intended Audience
1.6 Methodology
1.7 Information Sources
1.8 Analyst's Credentials
1.9 Custom Research
1.10 Related Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview
3.1 Proteomic Technologies
3.2 Scope of Report
3.3 Proteomics Market
3.4 Driving Forces for Proteomics Industry Growth
3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities
3.4.4 Challenge
3.4.5 Proteomics Industry

Chapter 4 COVID 19 Impact on Proteomics Market
4.1 Overview
4.2 COVID-19 Crisis
4.3 Impact on Market
4.4 Current Outlook
4.4.1 Implications on Cancer Diagnosis
4.4.2 Key Reasons for Impact of COVID-19

Chapter 5 Proteomics Technologies
5.1 Introduction
5.2 MS-Based Proteomics Technologies
5.2.1 Sample Preparation Assays
5.2.2 Tagging/Affinity Methods
5.2.3 Utility of Proteomics to Identify Biomarkers
5.2.4 MS Instruments and Consumables
5.3 Biochip-Based Proteomics Technologies
5.3.1 Multiplex Proteomics Systems
5.3.2 Proteogenomics
5.3.3 Recent Advances in Proteomics Technologies

Chapter 6 Proteomics Applications in Drug Discovery and Development
6.1 Target Discovery
6.2 Lead Identification
6.3 Lead Optimization
6.4 Preclinical Studies

Chapter 7 Proteomics Scientific Initiatives

Chapter 8 Clinical Proteomics Applications
8.1 Applications in Cancer
8.1.1 Overview
8.1.2 Bladder Cancer
8.1.3 Breast Cancer
8.1.4 Colorectal Cancer
8.1.5 Gastric Cancer
8.1.6 Kidney Cancer
8.1.7 Lung Cancer
8.1.8 Lymphomas
8.1.9 Ovarian Cancer
8.1.10 Pan-Cancer
8.1.11 Prostate Cancer
8.1.12 Thyroid Cancer
8.1.13 Other Cancers
8.2 Infectious Diseases
8.3 Diabetes
8.4 Neurological Disorders
8.4.1 Alzheimer's Disease
8.4.2 Schizophrenia
8.5 Immune Diseases
8.5.1 HLA Typing
8.5.2 Autoimmune Disease
8.6 Cardiovascular Disease
8.7 Preeclampsia
………….. ToC Continued

*More companies can be added in Detailed Report.

Access the complete market research report here - https://douglasinsights.com/proteomics-technologies-market

Set a budget for a custom project and see offers from publishers all over the world- https://douglasinsights.com/projects

About Douglas Insights-

Douglas insights UK limited is the first company to provide comparison of market research reports by table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.

Isabella Hawke
Douglas Insights
+ +44 7624 248772
email us here
Visit us on social media:
Twitter
LinkedIn